Abstract
Introduction
The implication of copy number variations in familial heart disease is known, although in-depth knowledge is lacking; hence, more studies are needed to further our understanding. Massively parallel sequencing, thanks to its recent surge in use, is emerging as a valid tool for the detection of this type of variant, through the use of appropriate software.
Methods
We conducted a study with 182 patients diagnosed with mendelian cardiovascular diseases who underwent sequencing using a cardiac gene panel and then a specific calling process for copy number variations (CNVs) with ExomeDepth software, which provides us with a Bayes factor (BF), a score of the probability that a CNV detected is true.
Results
After a rigorous CNV prioritization process, we confirmed the variants obtained by MLPA or SNP-based array, finding three real CNVs in five individuals in the MYH11, FBN1 and PDMI7 genes.
Conclusion
The confirmed CNVs present in all cases BF values > 60, thus establishing a threshold to consider real CNVs in the calling process carried out by ExomeDepth on our gene panel.
Similar content being viewed by others
References
Zarrei M, MacDonald JR, Merico D, Scherer SW. A copy number variation map of the human genome. Nat Rev Genet. 2015;16:172–83.
Zhao M, Wang Q, Wang Q, Jia P, Zhao Z. Computational tools for copy number variation (CNV) detection using next-generation sequencing data: features and perspectives. BMC Bioinform. 2013;14:S1.
Prakash SK, LeMaire SA, Guo D-C, Russell L, Regalado ES, Golabbakhsh H, et al. Rare copy number variants disrupt genes regulating vascular smooth muscle cell adhesion and contractility in sporadic thoracic aortic aneurysms and dissections. Am J Hum Genet. 2010;87:743–56.
Barc J, Briec F, Schmitt S, Kyndt F, Le Cunff M, Baron E, et al. Screening for copy number variation in genes associated with the long QT syndrome. J Am Coll Cardiol. 2011;57:40–7.
Norton N, Siegfried JD, Li D, Hershberger RE. Assessment of LMNA copy number variation in 58 probands with dilated cardiomyopathy. Clin Transl Sci. 2011;4:351–2.
Prakash S, Kuang S-Q, Regalado E, Guo D, Milewicz D. Recurrent rare genomic copy number variants and bicuspid aortic valve are enriched in early onset thoracic aortic aneurysms and dissections. PLoS ONE. 2016;11:e0153543.
Sonoda K, Ohno S, Ozawa J, Hayano M, Hattori T, Kobori A, et al. Copy number variations of SCN5A in Brugada syndrome. Heart Rhythm. 2018;15:1179–88.
Demirdas S, Dulfer E, Robert L, Kempers M, van Beek D, Micha D, et al. Recognizing the tenascin-X deficient type of Ehlers–Danlos syndrome: a cross-sectional study in 17 patients. Clin Genet. 2017;91:411–25.
Mates J, Mademont-Soler I, del Olmo B, Ferrer-Costa C, Coll M, Pérez-Serra A, et al. Role of copy number variants in sudden cardiac death and related diseases: genetic analysis and translation into clinical practice. Eur J Hum Genet. 2018;26:1014–25.
Vijay A, Garg I, Ashraf MZ. Perspective: DNA copy number variations in cardiovascular diseases. Epigenet Insights. 2018;11:251686571881883.
Mates J, Mademont-Soler I, Fernandez-Falgueras A, Sarquella-Brugada G, Cesar S, Arbelo E, et al. Sudden cardiac death and copy number variants: what do we know after 10 years of genetic analysis? Forensic Sci Int Genet. 2020;47: 102281.
Riggs ER, Andersen EF, Cherry AM, Kantarci S, Kearney H, Patel A, et al. Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen). Genet Med. 2020;22:245–57.
Boone PM, Bacino CA, Shaw CA, Eng PA, Hixson PM, Pursley AN, et al. Detection of clinically relevant exonic copy-number changes by array CGH. Hum Mutat. 2010;31:1326–42.
Zhang X, Du R, Li S, Zhang F, Jin L, Wang H. Evaluation of copy number variation detection for a SNP array platform. BMC Bioinform. 2014;15:50.
Stuppia L, Antonucci I, Palka G, Gatta V. Use of the MLPA assay in the molecular diagnosis of gene copy number alterations in human genetic diseases. Int J Mol Sci. 2012;13:3245–76.
Moreno-Cabrera JM, del Valle J, Castellanos E, Feliubadaló L, Pineda M, Brunet J, et al. Evaluation of CNV detection tools for NGS panel data in genetic diagnostics. Eur J Hum Genet. 2020;28:1645–55.
Plagnol V, Curtis J, Epstein M, Mok KY, Stebbings E, Grigoriadou S, et al. A robust model for read count data in exome sequencing experiments and implications for copy number variant calling. Bioinformatics. 2012;28:2747–54.
Royer-Bertrand B, Cisarova K, Niel-Butschi F, Mittaz-Crettol L, Fodstad H, Superti-Furga A. CNV detection from exome sequencing data in routine diagnostics of rare genetic disorders: opportunities and limitations. Genes. 2021;12:1427.
Ellingford JM, Campbell C, Barton S, Bhaskar S, Gupta S, Taylor RL, et al. Validation of copy number variation analysis for next-generation sequencing diagnostics. Eur J Hum Genet. 2017;25:719–24.
Marchuk DS, Crooks K, Strande N, Kaiser-Rogers K, Milko LV, Brandt A, et al. Increasing the diagnostic yield of exome sequencing by copy number variant analysis. PLoS ONE. 2018;13: e0209185.
Thorvaldsdottir H, Robinson JT, Mesirov JP. Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration. Brief Bioinform. 2013;14:178–92.
Yang H, Ma Y, Luo M, Zhao K, Zhang Y, Zhu G, et al. Identification of gross deletions in FBN1 gene by MLPA. Hum Genomics. 2018;12:46.
Takeda N, Morita H, Fujita D, Inuzuka R, Taniguchi Y, Nawata K, et al. A deleterious MYH11 mutation causing familial thoracic aortic dissection. Hum Genome Var. 2015;2:15028.
Arndt A-K, Schafer S, Drenckhahn J-D, Sabeh MK, Plovie ER, Caliebe A, et al. Fine mapping of the 1p36 deletion syndrome identifies mutation of PRDM16 as a cause of cardiomyopathy. Am J Hum Genet. 2013;93:67–77.
Green C, Ghali N, Akilapa R, Angwin C, Baker D, Bartlett M, et al. Classical-like Ehlers–Danlos syndrome: a clinical description of 20 newly identified individuals with evidence of tissue fragility. Genet Med. 2020;22:1576–82.
Samarakoon PS, Sorte HS, Kristiansen BE, Skodje T, Sheng Y, Tjønnfjord GE, et al. Identification of copy number variants from exome sequence data. BMC Genomics. 2014;15:661.
Kerkhof J, Schenkel LC, Reilly J, McRobbie S, Aref-Eshghi E, Stuart A, et al. Clinical validation of copy number variant detection from targeted next-generation sequencing panels. J Mol Diagn. 2017;19:905–20.
Retterer K, Scuffins J, Schmidt D, Lewis R, Pineda-Alvarez D, Stafford A, et al. Assessing copy number from exome sequencing and exome array CGH based on CNV spectrum in a large clinical cohort. Genet Med. 2015;17:623–9.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
This work was partially supported by Plan Estatal de I+D+i 2013-2016, Subdirección General de Evaluación y Fomento de la Investigación (ISCIII-SGEFI) from Instituto de Salud Carlos III (ISCIII) and Fondo Europeo de Desarrollo Regional (FEDER) (grant numbers PI19/01283, CB16/11/00226, CB06/07/0088).
Conflict of interest
The authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.
Ethics approval
This study was carried out following the guidelines of the Helsinki declaration, its later amendments and the approval of the Santiago-Lugo regional delegation of the Research Ethics Committee of Galicia (protocol code: 2014/295 and 2016/247).
Consent to participate and for publication
All patients who participated in this study signed an informed consent form.
Availability of data
The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.
Code availability
Not applicable.
Author contributions
AB-V had overall responsibility for the methodology, analysis and writing–original draft; BP contributed to methodology, data analysis and revising the manuscript; RG contributed to methodology and revising the manuscript; ER-L contributed to writing and revising the manuscript; MA-B contributed to methodology and revising the manuscript; BL-A contributed to methodology and revising the manuscript; BS contributed to methodology and revising the manuscript; JA contributed to methodology and revising the manuscript; JRG-J contributed to writing and revising the manuscript; ÁC contributed to writing and revising the manuscript; MB has responsibility for the overall execution of the study, contributed to writing and revising the manuscript.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Blanco-Verea, A., Piñeiro, B., Gil, R. et al. Detection of the Copy Number Variants of Genes in Patients with Familial Cardiac Diseases by Massively Parallel Sequencing. Mol Diagn Ther 27, 105–113 (2023). https://doi.org/10.1007/s40291-022-00624-z
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40291-022-00624-z